Delivery Order SPE2DB22D1106-SPE2DB24FDWV7
Award Date 1/24/24
Potential Completion Date 1/25/24
Potential Value $7.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of LIVALO 1 MG TABLET 90S. The contract has a potential value of $1,313.12 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order contract, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 and...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,262.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of LIVALO 1 MG TABLET 90S to support military treatment programs and facilities. This delivery order contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564134891 LIVALO 1 MG TABLET 90S. The contract has a ceiling value of $1,262.90 and a period of performance through April 2, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania...
- This federal contract award, with ID SPE2DX15D3020|SPE2DX23FXHLN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,185.76 firm-fixed-price delivery order is for the supply of the pharmaceutical product LIVALO 2 MG TABLET 90S. The contract has an ultimate completion date of August 8, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIVALO 2 MG TABLET 90S. The contract has a ceiling value of $1,273.59 and runs through August 6, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for $1,680.13. The order is for 90 tablets of the generic pharmaceutical Livalo, with a place of performance in Conshohocken, Pennsylvania. No set-aside designation was applied to this order, which has a completion date of November 15, 2023. As a prime contractor, Amerisourcebergen Drug Corp routinely supplies pharmaceuticals and medical supplies to DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a $31,173.70 firm fixed-price delivery order from the Defense Logistics Agency (DLA) for 4,567,280,072 LIVALO 2 MG TABLET 90S. The award has an ultimate completion date of February 18, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a $999,999,999 Indefinite...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at approximately $1,973 against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract. Under this order, Amerisourcebergen will provide 90 tablets of the cholesterol-lowering medication Livalo at 1 mg per tablet to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania. Performance is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,789.62, is for the supply of LIVALO 4 MG TABLET 90S, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of August 16, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, through its Corporate Office division, has...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,146.26, is for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of November 15, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDWV7Delivery Order
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 90 units of the 2 mg tablet form of the pharmaceutical drug LIVALO. The $7,360.75 order is in support of DLA Troop Support Medical programs and facilities. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous federal contracts from DLA to provide pharmaceuticals, medical supplies, and distribution services. No set-aside designation was used for this award, which has a completion date of January 25, 2024.
Generated 4/24/24, 10:48 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 1/24/24 |